Modulation of YrdC promotes hepatocellular carcinoma progression via MEK/ERK signaling pathway

Accumulating evidence suggested that YrdC involved in growth, telomere homeostasis, translation and the N6-threonylcarbamoylation (t6A) of tRNA was abnormally expressed in the progression of tumor. However, the role of YrdC in hepatocellular carcinoma remained elusive. Our study aimed to investigate...

Full description

Bibliographic Details
Main Authors: Shiqiong Huang, Peng Zhu, Bao Sun, Jun Guo, Honghao Zhou, Yan Shu, Qing Li
Format: Article
Language:English
Published: Elsevier 2019-06-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332218386888